Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Moderna's Loss in Q1 Was Less Than Expected
Moderna's Loss in Q1 Was Less Than Expected
Moderna's Loss in Q1 Was Less Than Expected
Submitted by
admin
on May 5, 2024 - 11:39pm
Source:
Motley Fool
News Tags:
Moderna Therapeutics
earnings
Headline:
Moderna's Loss in Q1 Was Less Than Expected
snippet:
Moderna's earnings per share exceeded analyst predictions but were still well down from 2023's Q1.
Revenue for Q1 showcased significant outperformance compared to analysts' forecasts.
Moderna reaffirmed its full-year 2024 financial outlook.
Do Not Allow Advertisers to Use My Personal information